Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

61.08

+0.02 (0.03%)

as of Aug 13, 2026, 3:27:42 pm Market Open.

1631 watching

Investor Insights

Aug 13, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has recently reported strong quarterly results, demonstrating solid performance in its operations, particularly in Hong Kong and Asia. However, the imposition of taxes by the Chinese government on MFC's products for mainland residents has raised concerns among investors. The company's valuation remains a topic of discussion, with some experts suggesting that MFC may be overbought and perceiving the financial sector in Canada as a whole to be slightly overvalued. While many analysts see potential in MFC due to its strong dividend yields and growth prospects, especially in Asia and wealth management, caution is advised regarding market conditions and potential pullbacks. Analysts recommend further observation of market dynamics, suggesting advantageous entry points should significant price corrections occur.

Consensus

Cautious

Valuation

Fair Value

Similar

SLF-T

WEAK BUY

Fair market value is only $42. Working very hard on the amalgamation of John Hancock so there is an unknown upside to come.

TOP PICK

With the closure of the John Hancock deal, should earn $4.50 next year. Good entry point.

BUY

Life-insurance companies will benefit from rising interest rates through their big bond portfolios.

HOLD

Has had a tremendous run-up in the last 3/4 weeks. Likes the management and feels the John Hancock acquisition will work out very well. Expects the uptrend will continue.

BUY

Very well-managed. Likes their diversification. Yield is low, but stock could continue going up.

BUY

Has a lot going for it. Likes their far Eastern operations.

BUY

Good management. Expect they will take a lot of costs out of the business with the acquisition of John Hancock. Expecting good Asian growth.

BUY ON WEAKNESS

Should be about to put up some good growth in earnings with their John Hancock acquisition. Expect some selling pressure when Hancock shareholders get their Manulife shares and start selling them. That will be an opportunity to buy.

BUY

Likes the life insurance business, this company in particular. Strong management. Expect they will be ruthless in cutting costs in John Hancock.

BUY

The merger with John Hancock was good and at a reasonable price. This should create cost synergies. Has a strong global presence.

BUY

Likes the insurance industry. Very solid company and well managed. A good hold.

BUY

The Hancock acquisition will add a lot over the next couple of years. Likes their position in Asia as well.

PAST TOP PICK

(A top pick December 16/03. Up 11.5%.) They consolidate very well. Good earnings.

DON'T BUY

Has done a very good job in its acquisition strategy. Will have some digesting problems with the John Hancock acquisition.

BUY

Can go a lot higher now that they John Hancock shareholders have agreed to the sale. Asian assets are now profitable. A good long-term hold.

Showing 2,026 to 2,040 of 2,284 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Chris Blumas

at Raymond James Investment Counsel Ltd.

Shannon Saccocia, CIO, Boston Private

Boston Private

Joe Terranova

Virtus Investment Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)